Protocol B1971011: A Phase 2, Randomized, Single-Blind Trial, To Asess the Safety, Tolerability and Immunogenicity of Gardasil Vaccine and rLP2086 Vaccine When Administered Concomitantly in Healthy Subjects Aged >/= 11 to </=17 Years